小分子剂的概述用于治疗皮肤肌肉炎
Xuechun Liu1,2, Ziwen Feng1,2, Chunchen Che1,2
1State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
Current topics in medicinal chemistry
|January 27, 2026
概括
皮质神经炎 (DM) 治疗需要更好的药物. 本综述探讨了针对DM的小分子,分析结构-活性关系和改进疗法的专利.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 自免疫性疾病 自免疫性疾病
背景情况:
- 皮肤肌肉炎 (DM) 是一种自身免疫性疾病.
- 目前的治疗方法包括葡萄糖皮质醇和免疫抑制剂.
- 需要更有效,更少的毒性疗法.
研究的目的:
- 审查最近在小分子药物发现中取得的进展.
- 分析小分子抑制剂的结构-活性关系 (SAR).
- 整合专利和临床证据,用于针对性DM疗法.
主要方法:
- 对DM的小分子抑制剂进行了全面的文献审查.
- 结构与活动关系 (SAR) 数据的分析.
- 整合最新的专利信息和临床试验结果.
主要成果:
- 确定有希望的小分子候选人用于DM治疗.
- 了解SAR用于DM路径的选择性向.
- 分子设计,临床证据和专利景观的综合.
结论:
- 小分子为新的DM疗法提供了一个有希望的途径.
- 有针对性的药物开发可以提高疗效,降低毒性.
- 分子设计和专利分析的进步指导了未来的DM治疗策略.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K
Myasthenia Gravis: Overview and Treatment
2.9K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
528
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
528
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
531
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
531
Molecules and Compounds
68.5K
Atoms and Molecules
68.5K
Subviral Agents
556
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
556


